Intellia Therapeutics Balance Sheet Health
Financial Health criteria checks 6/6
Intellia Therapeutics has a total shareholder equity of $971.1M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $1.2B and $220.5M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$691.07m |
| Equity | US$971.06m |
| Total liabilities | US$220.47m |
| Total assets | US$1.19b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 0JBU's short term assets ($757.2M) exceed its short term liabilities ($105.1M).
Long Term Liabilities: 0JBU's short term assets ($757.2M) exceed its long term liabilities ($115.4M).
Debt to Equity History and Analysis
Debt Level: 0JBU is debt free.
Reducing Debt: 0JBU has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 0JBU has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 0JBU has sufficient cash runway for 1.6 years if free cash flow continues to reduce at historical rates of 34% each year.